Shoji Kodama

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Noriyuki Katsumata, Makoto Yasuda, Fumiaki Takahashi et al. · The Lancet · 2009 · 733 citations

Medicine, Oncology, Pharmacology +12

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 481 citations

Medicine, Gynecology, Oncology +13

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Kimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa et al. · Journal of Clinical Oncology · 2007 · 413 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome

Tsunehisa Kaku, Hiroyuki Yoshikawa, Hitoshi Tsuda et al. · Cancer Letters · 2001 · 245 citations

Medicine, Gynecology, Oncology +13

Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection

Toyomi Satoh, Masayuki Hatae, Yoh Watanabe et al. · Journal of Clinical Oncology · 2010 · 208 citations

Medicine, Oncology, Surgery +16